BioSyent Inc.
RX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 40.67% | 20.72% | 20.56% | 18.94% | 13.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.67% | 20.72% | 20.56% | 18.94% | 13.33% |
| Cost of Revenue | 71.62% | 36.77% | 37.84% | 30.23% | 22.15% |
| Gross Profit | 32.04% | 16.33% | 16.10% | 16.02% | 11.10% |
| SG&A Expenses | 32.68% | 13.96% | 11.59% | 5.50% | 2.32% |
| Depreciation & Amortization | 262.47% | 243.51% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.04% | 22.09% | 20.99% | 14.26% | 9.76% |
| Operating Income | 23.47% | 16.87% | 19.33% | 33.77% | 24.24% |
| Income Before Tax | 20.22% | 16.07% | 20.52% | 22.33% | 13.86% |
| Income Tax Expenses | 22.55% | 15.92% | 17.76% | 35.27% | 19.63% |
| Earnings from Continuing Operations | 19.41% | 16.12% | 21.47% | 18.18% | 11.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.41% | 16.12% | 21.47% | 18.18% | 11.99% |
| EBIT | 23.47% | 16.87% | 19.33% | 33.77% | 24.24% |
| EBITDA | 32.68% | 21.23% | 22.64% | 35.02% | 24.71% |
| EPS Basic | 20.30% | 18.17% | 24.98% | 21.76% | 15.25% |
| Normalized Basic EPS | 20.40% | 16.01% | 18.88% | 30.58% | 21.72% |
| EPS Diluted | 20.11% | 18.00% | 24.61% | 21.54% | 14.96% |
| Normalized Diluted EPS | 20.26% | 15.73% | 18.49% | 30.23% | 21.30% |
| Average Basic Shares Outstanding | -0.78% | -1.82% | -2.80% | -2.93% | -2.76% |
| Average Diluted Shares Outstanding | -0.66% | -1.57% | -2.48% | -2.66% | -2.48% |
| Dividend Per Share | 10.66% | 11.37% | 8.90% | 8.24% | 8.37% |
| Payout Ratio | -0.08% | -0.06% | -0.13% | -0.11% | -0.06% |